Special Diabetes Program: Funding Opportunities

Below are current funding opportunities supported by the Special Diabetes Program. For other NIH funding opportunities, please see the NIH Guide for Grants and Contracts.

View archived research funding opportunities.

Posted Date Title Open Date (Earliest Submission Date) Application Due Date Full Announcement
8/29/2022 Clinical, Behavioral, and Physiological Studies of Open- and Closed-loop Platforms: Toward Personalized, Fully Automated, Accessible Systems (R01 Clinical Trial Required) January 28, 2023 February 28, 2023 and October 26, 2023 RFA-DK-22-020
7/29/2022 Integrated Physiology of Exocrine and Endocrine Pancreas in Type 1 Diabetes (R01 - Clinical Trial Not Allowed) January 21, 2023 February 21, 2023
RFA-DK-22-022
7/22/2022 Type 1 Diabetes Mellitus Stakeholder Engagement Innovation Center to Advance Health Equity (U2C Clinical Trial Not Allowed) October 17, 2022 November 17, 2022

RFA-DK-22-019

7/14/2022 Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes (T1D) Research (U01 Clinical Trial Not Allowed) September 26, 2022 October 26, 2022 RFA-DK-21-031
7/13/2022 Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed) September 26, 2022 October 26, 2022
RFA-DK-22-009
7/11/2022 Collaborative Research Using Biosamples from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed) January 28, 2023 February 28, 2023 and October 26, 2023
RFA-DK-22-021
12/3/2021  New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed) May 1, 2022 June 1, 2022 and March 20, 2023 RFA-DK-21-030
6/25/2021  Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) January 17, 2022 February 17, 2022 and October 7, 2022 RFA-DK-21-021
5/19/2021  Support for Small Business Innovation Research (SBIR) Development and Testing  of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) February 9, 2022  March 9, 2022 and October 7, 2022 RFA-DK-21-012
5/6/2021  Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed) February 9, 2022  March 9 and October 7, 2022  RFA-DK-21-011
1/3/2014 Diabetic Complications Consortium Preclinical Testing Program Ongoing Not Applicable DCC-PTP Website